Results 121 to 130 of about 19,999 (193)

Avatrombopag for the treatment of immune thrombocytopenia and thrombocytopenia of chronic liver disease

Journal of Blood Medicine, 2019
Abraham Z Cheloff, Hanny Al-Samkari Division of Hematology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USACorrespondence: Hanny Al-SamkariDivision of Hematology, Massachusetts General Hospital, Suite 118, Room 112, Zero Emerson ...
Cheloff AZ, Al-Samkari H
doaj  

Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts

, 2002
Background/Aims: Thrombocytopenia in chronic liver diseases may be related to deficient production of thrombopoietin. The aim of this study was to measure serum thrombopoietin levels and to examine the relationship between serum thrombopoietin ...
Koruk, M, Akcay, F, Savas, MC, Onuk, MD
core  

Thrombopoietin serum levels in patients with inflammatory bowel disease with and without previous thromboembolic events

, 2003
Patients affected by inflammatory bowel disease frequently suffer from thromboembolic complications and mesenteric microvascular occlusion could be involved in the pathogenesis of inflammatory bowel disease.
Danese, Silvio, Gasbarrini, Antonio, Grillo, Antonino, Gasbarrini, Giovanni Battista, Piccirillo, Nicola, Papa, Alfredo, Leone, Giuseppe   +6 more
core  

Citation clarification regarding feline eltrombopag in the "ACVIM consensus statement on the treatment of immune thrombocytopenia in dogs and cats". [PDF]

J Vet Intern Med
Kim J, Kwak D.
europepmc   +1 more source

The role of thrombopoietin and spleen volume in thrombocytopenia of patients with noncirrhotic and cirrhotic portal hypertension

, 2007
Background/aims: To determine the role of thrombopoietin and spleen volume in thrombocytopenia diagnosed in cirrhotic and noncirrhotic portal hypertensive patients. Methods: Seventy-four portal hypertensive patients (group 1: 28 noncirrhotic; group 2: 46
Yekeler, Ensar, Badur, Selim, Aksoy, Nevzat, Horasanli, Sibel, Oekten, Atilla, Poturoglu, Sule, Kaymakoglu, Sabahattin, Ibrisim, Duygu, Demir, Kadir, Akyuez, Filiz   +9 more
core  

Case Report: Prolonged thrombocytopenia after chemotherapy in solid tumors requiring long-term thrombopoietin receptor agonist support: a five-patient case series. [PDF]

Front Oncol
Wang S, Yu Y, Zhang L, Liu Q.
europepmc   +1 more source

Romiplostim for refractory chemotherapy-induced thrombocytopenia in a long-term survivor of limited-stage small cell lung cancer: a case report. [PDF]

Front Oncol
Wang M, Tian P, Huang T, Sun K, Liu J, Wang P.   +5 more
europepmc   +1 more source

A Paradoxical Case of Bleeding and Clots: The Hidden Thrombotic Threat in Immune Thrombocytopenic Purpura. [PDF]

Clin Case Rep
Sarker NK, Das S, Alam MK, Sarker SD, Rahman MH.   +4 more
europepmc   +1 more source

Circulating thrombopoietin and interleukin-6 in newly diagnosed autoimmune versus aplastic thrombocytopenia

, 1998
Circulating thrombopoietin and interleukin-6 concentrations were investigated in two different settings of thrombocytopenia. Twenty patients with autoimmune thrombocytopenic purpura (ATP), 12 patients with aplastic anemia (AA) and 15 healthy subjects ...
Kirazli, S., Buyukasik, Y., Ozcebe, O., HAZNEDAROĞLU, İBRAHİM CELALETTİN, Dundar, S., KOŞAR, ALİ   +5 more
core  

Thrombopoietin receptor agonists in inherited thrombocytopenias: an evolving mosaic of evidence. [PDF]

Res Pract Thromb Haemost
Zaninetti C.
europepmc   +1 more source